Table Of Contents

1 Introduction 
1.1 Industry Definition and Scope 
1.2 Research Methodology 
1.3 Executive Summary 
2 Market Environment 
2.1 Recent Trends and Outlook of Global Economy 
2.2 World Demographic Profile and Trends 
2.3 Global Healthcare Landscape 
2.4 China’s Healthcare and Regulation System 
3 Overview of Global Biomedicine Market 
3.1 World Biomedicine Market 2012-2020 
3.2 Distribution of World Biomedicine Market by Region 
3.3 Development Trends of Global Biomedical Industry 
4 Qualitative Analysis of China’s Biomedicine Market 
4.1 Value Chain Analysis 
4.2 Major Growth Drivers 
4.3 Market Restraints and Challenges 
4.4 Emerging Opportunities 
4.5 Key M&A, VCI, and IPO Trends 
5 Structure and Trend of China Biomedicine Market 
5.1 Overview of Biomedicine Market in China 2014-2020 
5.2 Therapeutic Protein 
5.3 Antibody 
5.4 Vaccines 
5.5 Blood Products 
5.6 Diagnostic Reagent 
5.7 China’s Biomedicine Market by Marketing Channel 
5.8 China’s Biomedical Market by Region 
6 Import and Export of Chinese Biomedicines 
6.1 China’s Biomedicine Exports 
6.2 China’s Biomedicine Imports 
7 Major Biomedicine Manufacturers 
7.1 Overview of Chinese Biomedicine Production 
7.2 Geographic Spread of Biomedicine Industry in China 
7.3 Company Profiles (20 Global Manufacturers and 32 Chinese Producers)

List Of Tables

Table 1.  Overview of World and China’s Biomedicine Market, 2012-2020, $ bn 
Table 2.  Average Annual Growth Rates of Global Real GDP, Outlook to 2030, % 
Table 3.  Population Estimates, by Region, 2010 and 2050 (millions) 
Table 4.  Per Capita Total Expenditure on Health at Average Exchange Rate by Country 2003-2012 (US$) 
Table 5. World Biomedicine Market by Sub-Product, 2012-2020, $ bn 
Table 6. World Top 20 Biomedicine Manufacturers in 2014, $bn 
Table 7.  Geographic Spread of China Biomedicine Market by Profit, 2014 
Table 8.  Output Value of China’s Pharmaceutical and Biomedicine Manufacture Industry, 2010-2020, $ bn 
Table 9.  China Top Biomedicine Companies by Revenue, 2013Q1-Q3, RMB million

List Of Figures

Figure 1.  Recent Growth Trend of World Gross Product, 2008–2016 
Figure 2.  Global Population Estimates by Age, 2000-2050 (millions) 
Figure 3.  Global Population Estimates by Age, 2000-2050 (%) 
Figure 4.  Regional Distribution of the Global Population of People 65 and Older, 2010 and 2050, %
Figure 5.  Total Health Expenditure as a Percentage of GDP for Major Economies (2013) 
Figure 6. Global Biomedicine Market and Growth Rate, 2012-2020 
Figure 7. Trend of Global Biosimilar Sales and Its Share in Biomedicine Market, 2012-2020 
Figure 8. Geographic Distribution of Global Biomedicine Market by Region, 2014, $bn 
Figure 9. Geographic Distribution of Global Biomedicine Market by Region, 2020, $bn 
Figure 10.  A Typical Value Chain in Biomedical R&D Pipeline 
Figure 11.  China Biomedicine Market Trend and Share in the Global Market, 2012-2020 
Figure 12.  China Therapeutic Protein Market and Share, 2012-2020, $bn 
Figure 13.  China Antibody Market and Share, 2012-2020, $bn 
Figure 14.  China Vaccine Market and Share, 2012-2020, $bn 
Figure 15.  China Blood Products Market and Share, 2012-2020, $bn 
Figure 16.  China Diagnostic Reagent Market and Share, 2012-2020, $bn 
Figure 17. Sales Share of China’s Biomedicines by Marketing Channel, 2012-2020 
Figure 18.  Export Value of China’s Biomedicines and Overall Pharmaceuticals, 2010-2020 
Figure 19.  Import Value of China’s Biomedicines and Overall Pharmaceuticals, 2010-2020 

selected global companies:
Pfizer, Inc.
Novartis International AG
Merck & Co., Inc.
F. Hoffmann-La Roche AG
Sanofi S.A.
Eli Lilly and Company 
Selected Chinese companies:
Beijing Tiantan Biological Products Co., Ltd.
Shanghai Kehua Bio-engineering Co., Ltd
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Biotech Pharmaceutical Co., Ltd. (BPL)
Innovent Biologics, Inc.
Zhuhai Livzon MAB Biological Technology Company Ltd.